Home Tags IKS04

Tag: IKS04

Iksuda Therapeutics Closes Financing Round with Mirae Asset Capital, Celltrion and...

A developer of a new generation of antibody-drug conjugates, Iksuda Therapeutics, has completed a US $47 million (UK £34 million) financing round.  The financing...

X